No one-size-fits-all dialysis for acute kidney injury, suggests research
For someone in an intensive care unit whose kidneys suddenly stop working, deciding how to provide kidney support can be as important as deciding when to start it. Some patients need dangerous levels of potassium removed rapidly. Others are in shock, cannot tolerate abrupt changes in blood pressure, or have brain injuries that make rapid shifts in body fluids especially risky.
In the Journal of Intensive Medicine, Brazilian researchers examine these competing needs. The evidence, made available online on September 29, 2026, does not show a consistent survival advantage for any dialysis method. Instead, different techniques offer different strengths, which should be matched to the patient's condition and reassessed as that condition changes.
Acute kidney injury, a sudden decline in kidney function, can affect more than half of critically ill patients. Among intensive care patients who develop the condition, approximately 10%–15% receive kidney replacement therapy, a form of treatment that removes waste products and excess fluid when the kidneys cannot do so adequately. Choosing the right approach can be particularly difficult when organ failure, unstable circulation, and fluid overload occur together.
What the evidence can (and cannot) tell us
The researchers conducted a structured, non-systematic search of PubMed/MEDLINE, Embase, and the Cochrane Library through March 16, 2026, giving priority to clinical trials, systematic reviews, meta-analyses, and clinical guidelines.
Across comparisons of intermittent hemodialysis, prolonged intermittent treatment, continuous treatment, and peritoneal dialysis, studies have not established a consistent mortality benefit for any one technique. However, this does not mean the methods are interchangeable in every situation: many studies were small, involved different patient populations, or allowed patients to switch therapies, limiting definitive comparisons.
Matching the treatment to the problem
Conventional intermittent hemodialysis works relatively quickly and is often appropriate for patients with stable circulation, especially when dangerously high potassium levels or certain poisonings require rapid clearance. Continuous kidney replacement therapy removes wastes and fluid more gradually, making it an important option when severe hemodynamic instability prevents safe fluid removal during shorter treatments. Continuous methods are also generally preferred when rapid changes in blood chemistry could worsen brain swelling.
Prolonged intermittent therapies, sometimes called hybrid dialysis, extend treatment over several hours and may offer a middle ground between rapid and continuous approaches. Peritoneal dialysis, which uses the lining of the abdomen rather than an extracorporeal blood circuit, can be suitable for selected patients and is especially relevant where machines, consumables, or specialized staffing are limited. Its use still depends on clinical suitability and local expertise, and evidence supporting broader use in critically ill adults remains limited.
Importantly, the review cautions against using a fixed dose of blood-pressure-supporting medication as an automatic trigger for continuous dialysis: no such threshold has been validated by high-quality evidence.
A changing plan, not a permanent label
The authors advocate repeated bedside assessment by nephrologists, intensive care clinicians, and the wider multidisciplinary team. As circulation improves, fluid overload changes, or metabolic emergencies resolve, a patient may benefit from moving between methods rather than remaining on the treatment first chosen.
They also argue that future studies should look beyond survival alone. Recovery of kidney function, freedom from ongoing dialysis, control of fluid balance, time spent in hospital, and quality of life matter to patients and families. Larger, well-designed trials are needed to learn which strategies best serve particular groups of critically ill patients.
The practical conclusion is clear: kidney replacement therapies should be viewed as complementary tools, not competing winners. The aim is to choose, and keep adjusting, the treatment that safely meets the patient's most urgent needs.
Reference:
Pablo Rodrigues Costa-Alves, Fabiano Bichuette Custódio, Andreia Craveiro Franco, Roberto Freire Alves Junior, André Luís Balbi, Welder Zamoner, Daniela Ponce, Kidney replacement therapy in acute kidney injury: Evidence to guide clinical decision-making, Journal of Intensive Medicine, 2026, https://doi.org/10.1016/j.jointm.2026.08.006.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.